GlassScriptPhysician profile
Manasvi Gupta
NPI 1780249813
$24,213.26
in general payments reported to CMS, 2019-2025
10 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $135 · 2023: $265 · 2024: $9,594 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Food and Beverage: $8,958 · Education: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,760.71 |
| Food and Beverage | $8,958.10 |
| Education | $359.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,374.11 | 2023-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $4,138.45 | 2025 | Accolade Sr, Emblem Mri S-Icd |
| Biotronik INC. | $4,034.65 | 2025 | |
| Abbott Laboratories | $2,434.26 | 2025 | Ensite, Gallant, Aveir |
| Medical Device Business Services, INC. | $1,633.12 | 2024 | Carto 3 |
| Biosense Webster, INC. | $323.32 | 2024-2025 | Carto 3 |
| Amgen INC. | $116.21 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $93.09 | 2023 | |
| Abiomed | $47.58 | 2025 | |
| Lantheus Medical Imaging, INC. | $18.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manasvi Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.